Search research articles
Contact Us
Filters
Showing results (1461-1470 of 1,632) with videos related to
Page
of 164
Sort By:
Movement Disorders Clinical Practice
|
March 5, 2025
Long-Term Quality of Life Trend after Subthalamic Stimulation for Parkinson's Disease: An Updated Systematic Review and Meta-Analysis
Luis Otávio Nogueira, Angela Maria Sandini Corso, Louise Dalla Corte Dallé, et al.
The Journal of Pain
|
April 10, 2024
Assessment of Human Fetuses Undergoing Acute Pain: Validation of the Fetal-7 Scale
Lisandra S Bernardes, Ana M Fernandes, Mariana A Carvalho, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 11, 2015
COX-2 rs20417 Polymorphism Is Associated with Stroke and White Matter Disease
Jamary Oliveira-Filho, Ana C P Ornellas, Cathy R Zhang, et al.
Current Biology : CB
|
July 13, 2021
Genome-scale sequencing and analysis of human, wolf, and bison DNA from 25,000-year-old sediment
Pere Gelabert, Susanna Sawyer, Anders Bergström, et al.
Leukemia
|
November 7, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia
Deepti Gadi, Alec Griffith, Svitlana Tyekucheva, et al.
Frontiers in Public Health
|
October 5, 2020
Comparison of Commercial ELISA Kits to Confirm the Absence of Transmission in Malaria Elimination Settings
Lotus L van den Hoogen, Paolo Bareng, Joana Alves, et al.
International Journal of Cardiology
|
August 31, 2016
Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study
Paul Khairy, Jamil Aboulhosn, Craig S Broberg, et al.
BMJ Open
|
January 4, 2023
International variation in evidence-based emergency department management of bronchiolitis: a retrospective cohort study
Marie-Pier Lirette, Nathan Kuppermann, Yaron Finkelstein, et al.
Haematologica
|
May 7, 2013
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Jennifer R Brown, Bradley Messmer, Lillian Werner, et al.
Blood Advances
|
April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia
Benjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Page
of 164
Search research articles
Search
Showing results (1461-1470 of 1,632) with videos related to
Sort By:
Page
of 164
Movement Disorders Clinical Practice
|
March 5, 2025
Long-Term Quality of Life Trend after Subthalamic Stimulation for Parkinson's Disease: An Updated Systematic Review and Meta-Analysis
Luis Otávio Nogueira, Angela Maria Sandini Corso, Louise Dalla Corte Dallé, et al.
The Journal of Pain
|
April 10, 2024
Assessment of Human Fetuses Undergoing Acute Pain: Validation of the Fetal-7 Scale
Lisandra S Bernardes, Ana M Fernandes, Mariana A Carvalho, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
May 11, 2015
COX-2 rs20417 Polymorphism Is Associated with Stroke and White Matter Disease
Jamary Oliveira-Filho, Ana C P Ornellas, Cathy R Zhang, et al.
Current Biology : CB
|
July 13, 2021
Genome-scale sequencing and analysis of human, wolf, and bison DNA from 25,000-year-old sediment
Pere Gelabert, Susanna Sawyer, Anders Bergström, et al.
Leukemia
|
November 7, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia
Deepti Gadi, Alec Griffith, Svitlana Tyekucheva, et al.
Frontiers in Public Health
|
October 5, 2020
Comparison of Commercial ELISA Kits to Confirm the Absence of Transmission in Malaria Elimination Settings
Lotus L van den Hoogen, Paolo Bareng, Joana Alves, et al.
International Journal of Cardiology
|
August 31, 2016
Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study
Paul Khairy, Jamil Aboulhosn, Craig S Broberg, et al.
BMJ Open
|
January 4, 2023
International variation in evidence-based emergency department management of bronchiolitis: a retrospective cohort study
Marie-Pier Lirette, Nathan Kuppermann, Yaron Finkelstein, et al.
Haematologica
|
May 7, 2013
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Jennifer R Brown, Bradley Messmer, Lillian Werner, et al.
Blood Advances
|
April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia
Benjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Page
of 164